Search results
Results from the WOW.Com Content Network
Tumors smaller than 1–2 mm in diameter are delivered oxygen and nutrients through passive diffusion. In larger tumors the center becomes too far away from the existing blood supply, leading the tumor microenvironment to become hypoxic and acidic. [16] Angiogenesis is upregulated to feed the cancer cells and is linked to tumor malignancy. [17]
An illustration depicting primary tumor (in the form of tumor microenvironment) and the circulating tumor cells. A circulating tumor cell (CTC) is a cancer cell from a primary tumor that has shed into the blood of the circulatory system, or the lymph of the lymphatic system. [1]
Oncology is a branch of medicine that deals with the study, treatment, diagnosis, and prevention of cancer. A medical professional who practices oncology is an oncologist. [1] The name's etymological origin is the Greek word ὄγκος (ónkos), meaning "tumor", "volume" or "mass". [2] Oncology is concerned with:
Lung cancer has the highest mortality rate in comparison to other forms of cancer, with the leading cause of development due to smoking. [27] The number of smokers in China is rapidly increasing with tobacco killing approximately 3000 people each day. [27] The diagnosis of lung cancer is most common within the 50–59-year age bracket. [26]
The hallmarks of cancer were originally six biological capabilities acquired during the multistep development of human tumors and have since been increased to eight capabilities and two enabling capabilities. The idea was coined by Douglas Hanahan and Robert Weinberg in their paper "The Hallmarks of Cancer" published January 2000 in Cell. [1]
Relapse is a term to describe returning symptoms of the disease after a period of remission. In cancer-treatment, doctors usually avoid the term "cured" and instead prefer the term "no evidence of disease" (NED) to refer to a complete remission of cancer, which does not rule out the possibility of relapse. [3] [4]
Today, renal cell carcinoma (RCC) is often asymptomatic, meaning it presents no symptoms, and is commonly detected incidentally during examinations for unrelated medical conditions. The percentage of asymptomatic and incidentally diagnosed RCC cases, particularly smaller tumors, has continued to rise in recent years.
Pan-cancer studies aim to detect the genes whose mutation is conducive to oncogenesis, as well as recurrent genomic events or aberrations between different tumors.For these studies, it is necessary to standardize the data between multiple platforms, establishing criteria between different researchers to work on the data and present the results.